| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/22/2013 | CN102382843B Sword-leaved cymbidium flowering integrator gene (CeFT gene) and application thereof |
| 05/22/2013 | CN102382187B FBXL15 protein fragment, coding gene thereof, and application of FBXL15 protein fragment and coding gene |
| 05/22/2013 | CN102311497B Method for recovering albumin from component IV deposition by low temperature ethanol method |
| 05/22/2013 | CN102311496B Method for recovering albumin from deposited components I+II+III from cold ethanol method |
| 05/22/2013 | CN102295692B Rice metal-tolerant protein OsMTP1 as well as encoding gene and RNA (Ribonucleic Acid) interference segment thereof |
| 05/22/2013 | CN102286088B DREB (Dehydration Responsive Element Binding) transcription factor of plant as well as encoding gene and application thereof |
| 05/22/2013 | CN102146134B Method for efficiently extracting and purifying blood coagulation factor IX and blood coagulation factor X |
| 05/22/2013 | CN101934069B Application of neuroglobin in promoting neurite growth |
| 05/22/2013 | CN101469019B Cellular membrane protein DERLIN-1, preparation and use thereof |
| 05/22/2013 | CN101365793B Polypeptide extracted from plants of the genus lupinus or produced in recombinant form, nucleotide sequence encoding it and its use in animal nutrition, as a plant growth promoter and in the fight aga |
| 05/22/2013 | CN101355928B Compositions and methods for cancer immunotherapy |
| 05/22/2013 | CN101189254B 疫苗 Vaccine |
| 05/21/2013 | US8445763 Inbred maize variety PH184C |
| 05/21/2013 | US8445762 Inbred maize variety PH18DR |
| 05/21/2013 | US8445749 Bacillus thuringiensis gene with lepidopteran activity |
| 05/21/2013 | US8445745 Animal model having a chimeric human liver and susceptible to human hepatitis C virus infection |
| 05/21/2013 | US8445665 Therapeutic compositions |
| 05/21/2013 | US8445660 Chimeric vaccines |
| 05/21/2013 | US8445658 Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species |
| 05/21/2013 | US8445647 Modified exendins and exendin agonists |
| 05/21/2013 | US8445646 Therapeutic use of anti-CS1 antibodies |
| 05/21/2013 | US8445644 ErbB interface peptidomimetics and methods of use thereof |
| 05/21/2013 | US8445640 Bacillus thuringiensis gene with lepidopteran activity |
| 05/21/2013 | US8445639 Recombinant bacteriophage and methods for their use |
| 05/21/2013 | US8445635 Modified H2 relaxin for tumor suppression |
| 05/21/2013 | US8445455 Stress-responsive induction of a therapeutic agent and methods of use |
| 05/21/2013 | US8445445 Method of promoting hair growth using FGFR4 extracellular domains |
| 05/21/2013 | US8445444 Compositions and methods for diagnosing, treating, and preventing prostate conditions |
| 05/21/2013 | US8445442 CCL18 and CCL3 methods and compositions for detecting and treating cancer |
| 05/21/2013 | US8445441 Inhibitors of BCL-2 |
| 05/21/2013 | US8445435 Mast cell stabilizers in the treatment of obesity |
| 05/21/2013 | US8445429 Lactoferrin and neuronal health and development in the infant gut |
| 05/21/2013 | US8445425 Urocortin-III and uses thereof |
| 05/21/2013 | US8445283 Methods for producing biological substances in enzyme-deficient mutants of Aspergillus niger |
| 05/21/2013 | US8445251 Rationally-designed single-chain meganucleases with non-palindromic recognition sequences |
| 05/21/2013 | US8445234 Methods of making VEGF-D polypeptides |
| 05/21/2013 | US8445233 PGC-1β, a novel PGC-1 homologue and uses therefor |
| 05/21/2013 | US8445227 N-acetylglucosaminyltransferase III expression in lower eukaryotes |
| 05/21/2013 | US8445001 Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto |
| 05/21/2013 | US8445000 Immunogenic compositions of Staphylococcus epidermidis polypeptide antigens |
| 05/21/2013 | US8444995 Peptide sequences and compositions |
| 05/21/2013 | US8444990 Antibody-induced apoptosis |
| 05/21/2013 | US8444987 Compositions and methods for the diagnosis and treatment of immune disorders |
| 05/21/2013 | US8444980 Therapeutic use of anti-CS1 antibodies |
| 05/21/2013 | US8444979 Antibodies that inhibit TSLP activity |
| 05/21/2013 | US8444964 Compositions and methods for enhanced tumor cell immunity in vivo |
| 05/21/2013 | CA2717276C Selenium containing modifying agents and conjugates |
| 05/21/2013 | CA2576519C Il-1 antagonist formulations |
| 05/21/2013 | CA2566101C Novel soluble cd14 antigen |
| 05/21/2013 | CA2561830C Monoclonal antibodies with specificity for fetal erythroid cells |
| 05/21/2013 | CA2522614C Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry |
| 05/21/2013 | CA2519285C Papanicolau staining process |
| 05/21/2013 | CA2496321E Biomarkers for diagnosing alzheimer's disease |
| 05/21/2013 | CA2496321C Biomarkers for diagnosing alzheimer's disease |
| 05/21/2013 | CA2477675C Immunizing composition and method for inducing an immune response against the .beta.-secretase cleavage site of amyloid precursor protein |
| 05/21/2013 | CA2468179C Method for producing l-amino acids using bacteria belonging to the genus escherichia |
| 05/21/2013 | CA2436666C Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 05/21/2013 | CA2401638C Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 05/21/2013 | CA2399080C Humanized anti-ccr2 antibodies and methods of use therefor |
| 05/21/2013 | CA2370405C Nucleic acid molecules from wheat, transgenic plant cells and plants and the use thereof for the production of modified starch |
| 05/21/2013 | CA2360146C Methods for inhibiting brain tumor growth by using selected integrin antagonists |
| 05/21/2013 | CA2305385C Human toll homologues |
| 05/16/2013 | WO2013071231A1 Channelrhodopsins for optical control of cells |
| 05/16/2013 | WO2013071168A1 Polypeptide substrate for the detection of von willebrand factor cleaving protease adamts13 |
| 05/16/2013 | WO2013071039A1 Macrocyclic compounds for inhibition of inhibitors of apoptosis |
| 05/16/2013 | WO2013070796A2 Propeptide-luciferase fusion proteins and methods of use thereof |
| 05/16/2013 | WO2013070734A1 Methods of cardiac repair |
| 05/16/2013 | WO2013070076A1 Fusion protein comprising an interleukin 4 and interleukin |
| 05/16/2013 | WO2013068847A2 Compositions and methods for treatment of cytomegalovirus |
| 05/16/2013 | WO2013068603A2 Methods for refolding g-csf from inclusion bodies |
| 05/16/2013 | WO2013068476A1 Neurotoxins exhibiting shortened biological activity |
| 05/16/2013 | WO2013068472A1 Modified neurotoxins with poly-glycine and uses thereof |
| 05/16/2013 | WO2013068430A2 High mast2-affinity polypeptides and uses thereof |
| 05/16/2013 | WO2013068413A1 Rod cell-specific promoter |
| 05/16/2013 | WO2013067750A1 Polyclonal antibody immunologic mass spectrometry kit of liver cancer marker |
| 05/16/2013 | WO2013067608A1 Immunomodulating compound for the treatment of cancerous tumours that are located in the internal and external epithelial tissue |
| 05/16/2013 | WO2013041877A3 Influenza virus mutant expressing a haemagglutinin protein without functional signal sequence for use as vaccine |
| 05/16/2013 | WO2012174534A3 Method of treating or ameliorating metabolic disorders using clec-2 |
| 05/16/2013 | US20130125268 Plant haemoglobin |
| 05/16/2013 | US20130123484 Position dependent recognition of gnn nucleotide triplets by zinc fingers |
| 05/16/2013 | US20130123462 Amide based glucagon superfamily peptide prodrugs |
| 05/16/2013 | US20130123460 Peptide for improving biostability of bioactive substance, and bioactive substance having improved biostability |
| 05/16/2013 | US20130123349 Aegyptin and uses thereof |
| 05/16/2013 | US20130123200 Mammalian cell surface antigens; related reagents |
| 05/16/2013 | US20130123187 Peptides for the regulation of neurotransmitter sequestration and release |
| 05/16/2013 | US20130123182 Identification and molecular characterisation of proteins, expressed in the ixodes ricinus salivary glands |
| 05/16/2013 | US20130123181 Factor VIII T Cell Epitope Variants Having Reduced Immunogenicity |
| 05/16/2013 | US20130123178 Glucagon superfamily peptides exhibiting nuclear hormone receptor activity |
| 05/16/2013 | US20130123175 Compounds for Delivery of Therapeutic And Imaging Moieties to Nerve Cells |
| 05/16/2013 | US20130123173 Creation of oxidation-resistant hdl mimetic peptides |
| 05/16/2013 | US20130123171 Amide-based insulin prodrugs |
| 05/16/2013 | US20130123170 Growth Hormone Releasing Peptides |
| 05/16/2013 | US20130123169 Peptidomimetic macrocycles |
| 05/16/2013 | US20130123122 Secreted proteins and uses thereof |
| 05/16/2013 | US20130122590 Akt ligands and polynucleotides encoding akt ligands |
| 05/16/2013 | US20130122585 Synthetic gagpol genes and their uses |
| 05/16/2013 | US20130122547 Yeast host, transformant and method for producing heterologous proteins |
| 05/16/2013 | US20130122525 smFRET WITH MEMBRANE PROTEINS |
| 05/16/2013 | US20130122047 Streptococcus pyogenes antigens |
| 05/16/2013 | US20130122043 Modified polypeptides and proteins and uses thereof |